| Catalog_no |
ADMC0947 |
| Product_name |
Palbociclib |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
780.00/1000.00/1440.00 |
| Specificity |
Target: CDK . Fields: Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Dilution |
IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Purification |
>98% |
| Concentration |
靶点：CDK;IC50： 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
PD0332991; PD-0332991; PD 0332991 |
| Molecular Weight |
447.53 |
| Notes |
Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Instructions |
 查看与下载 |
